Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CBUS

Cibus Inc

May 10 • 04:00PM ET

17.74

Dollar change -0.11
Percentage change -0.62	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-18.35	Insider Own	33.48%	Shs Outstand	21.24M	Perf Week	3.99%
Market Cap	383.54M	Forward P/E	-	EPS next Y	-2.35	Insider Trans	7.69%	Shs Float	14.38M	Perf Month	-2.79%
Income	-285.67M	PEG	-	EPS next Q	-0.99	Inst Own	26.59%	Short Float	3.22%	Perf Quarter	-2.98%
Sales	2.32M	P/S	165.32	EPS this Y	88.44%	Inst Trans	-17.16%	Short Ratio	6.91	Perf Half Y	40.91%
Book/sh	13.24	P/B	1.34	EPS next Y	21.67%	ROA	-103.26%	Short Interest	0.46M	Perf Year	1.45%
Cash/sh	1.13	P/C	15.65	EPS next 5Y	-	ROE	-203.41%	52W Range	8.90 - 38.85	Perf YTD	-9.67%
Dividend Est.	-	P/FCF	-	EPS past 5Y	10.61%	ROI	-97.03%	52W High	-54.34%	Beta	1.97
Dividend TTM	-	Quick Ratio	1.37	Sales past 5Y	837.06%	Gross Margin	-332.80%	52W Low	99.33%	ATR (14)	1.05
Dividend Ex-Date	-	Current Ratio	1.23	EPS Y/Y TTM	19.76%	Oper. Margin	-3597.16%	RSI (14)	52.37	Volatility	4.91% 5.96%
Employees	-	Debt/Eq	0.08	Sales Y/Y TTM	1289.22%	Profit Margin	-12313.28%	Recom	1.67	Target Price	23.00
Option/Short	Yes / Yes	LT Debt/Eq	0.06	EPS Q/Q	89.71%	Payout	-	Rel Volume	0.75	Prev Close	17.85
Sales Surprise	36.25%	EPS Surprise	-10.89%	Sales Q/Q	1197.62%	Earnings	May 09 AMC	Avg Volume	67.03K	Price	17.74
SMA20	7.36%	SMA50	-3.63%	SMA200	4.39%	Trades		Volume	50,516	Change	-0.62%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-09-23	Initiated	H.C. Wainwright	Buy	$25
Jul-19-23	Resumed	Canaccord Genuity	Buy	$30

May-09-24 10:55PM	CBUS Stock Earnings: Cibus Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:05PM	Cibus Reports First Quarter Financial Results and Provides Business Update (GlobeNewswire)
Apr-25-24 07:00AM	Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call (GlobeNewswire)
Mar-25-24 03:16PM	Cibus (CBUS) Reports Q4 Loss, Tops Revenue Estimates (Revised) (Zacks) +5.25%
Mar-22-24 01:03PM	Cibus, Inc. (NASDAQ:CBUS) Q4 2023 Earnings Call Transcript (Insider Monkey) +9.10%
08:52PM	Loading…
Mar-21-24 08:52PM	CBUS Stock Earnings: Cibus Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace) -9.01%
04:05PM	Cibus Reports Fourth Quarter Financial Results and Provides Business Update (GlobeNewswire)
Mar-19-24 08:30AM	Cibus Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024 (GlobeNewswire) -6.80%
Mar-18-24 08:26AM	Cibus (CBUS) Moves 6.7% Higher: Will This Strength Last? (Zacks) +5.13%
Mar-13-24 07:35AM	Cibus to Participate in the 36th Annual Roth Conference (GlobeNewswire)
Mar-07-24 07:00AM	Cibus to Report Fourth Quarter 2023 Financial Results on March 21, 2024 and Host Conference Call (GlobeNewswire)
Feb-26-24 07:00AM	Cibus and Loveland Products Collaborate to Develop and Sell Rice Traits in the US (GlobeNewswire)
Feb-07-24 12:51PM	European Parliament Votes to Support Proposal for the Regulation of New Genomic Techniques (GlobeNewswire)
Jan-25-24 04:30PM	European Parliaments Environment Committee Votes to Support New Proposal for the Regulation of New Genomic Techniques (GlobeNewswire)
Jan-17-24 07:00AM	Cibus 2023 Field Trial Results Move Developed Traits Closer to Product Sales (GlobeNewswire)
07:00AM	Loading…
Jan-09-24 07:00AM	Cibus Announces Major Breakthrough in Wheat Regeneration from Single Cells (GlobeNewswire) +6.27%
Jan-04-24 07:30AM	Cibus Enters into a Latin America Collaboration Agreement with Interoc to deliver rice growers an innovative rice weed control system (GlobeNewswire)
Dec-12-23 07:30AM	Cibus Announces $20.3 Million Registered Direct Offering (GlobeNewswire)
Dec-01-23 08:00AM	European Union Notifies Trading Partners on the Proposal for the Regulation of Plants Obtained from New Genomic Techniques (GlobeNewswire) +10.34%
Nov-30-23 08:00AM	Cibus Announces New Publication: Industrial Scale Gene Editing in Brassica napus (GlobeNewswire)
Nov-09-23 04:05PM	Cibus Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-06-23 08:00AM	European Parliament Releases Draft Report on the Proposal for the Regulation of Plants Obtained from New Genomic Techniques (GlobeNewswire)
Nov-02-23 04:05PM	Cibus to Report Third Quarter 2023 Financial Results on November 9, 2023 and Host Conference Call (GlobeNewswire)
Oct-09-23 09:33AM	Oracle upgraded, Spotify downgraded: Wall Street's top analyst calls (The Fly) -8.67%
Sep-18-23 05:23PM	Jim Collins to Join Cibus Board of Directors (GlobeNewswire) +15.85%
Sep-05-23 08:00AM	Cibus to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire) +11.27%
Aug-09-23 05:00PM	Cibus Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Aug-03-23 12:30PM	Steve Berreth Appointed as General Counsel and Corporate Secretary (GlobeNewswire) +5.33%
07:00AM	Cibus to Report Second Quarter 2023 Financial Results on August 10, 2023 and Host Conference Call (GlobeNewswire)
Aug-02-23 04:05PM	Cibus to Present at the Canaccord 43rd Annual Growth Conference (GlobeNewswire)
08:30AM	Loading…
Jul-12-23 08:30AM	Cibus Opens Dedicated, High-throughput Gene Editing Facility for Trait Production (GlobeNewswire)
Jul-05-23 04:05PM	Cibus Welcomes European Commission Proposal on Regulation of Plants Obtained from New Genomic Techniques (GlobeNewswire) +26.93%
Jun-15-23 08:45AM	Cibus Applauds the Genetic Technology (Precision Breeding) Act 2023 Passed in the United Kingdom (GlobeNewswire) +10.78%
07:00AM	Cibus to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jun-07-23 07:00AM	Cibus White Mold Resistance Trait in Canola Achieves Another Important Milestone (GlobeNewswire)
Jun-01-23 07:00AM	Cibus Announces Closing of Merger with Calyxt to Create Industry Leading Precision Gene Editing and Trait Development Company (GlobeNewswire) -17.30%

Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. It focuses on using gene editing to develop productivity traits in major agricultural crops such as Canola, Rice, Soybean, Corn and Wheat. The company was founded in 2010 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
RIGGS RORY B	Chief Executive Officer	Dec 12 '23	Buy	10.58	517,107	5,470,992	1,622,495	Dec 14 05:10 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CBUS

Cibus Inc

Upgrade your FINVIZ experience